Siren »

Regenxbio Inc equity us cm shares owned by Siren

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by Siren from 13F filings

Historical chart of Siren investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0M 284k 10.49

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Regenxbio Inc equity us cm

BlackRock
BlackRock
Vanguard Group
Redmile Group
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Dimensional Fund Advisors
Avidity Partners Management
Geode Capital Management
Aquilo Capital Management
Balyasny Asset Management
Goldman Sachs Group
Assenagon Asset Management
MPM Oncology Impact Management

View all funds holding Regenxbio Inc equity us cm